Nox Research Library
Research Library
Plain-language, source-cited explainers for researchers. All materials referenced are for research use only, not for human or veterinary consumption. See our editorial standards.
Retatrutide vs Tirzepatide vs Semaglutide: A Research Compound Comparison
How the published literature classifies retatrutide, tirzepatide, and semaglutide as research compounds: drug class, receptor mechanism, and trial status, cited to NEJM and ClinicalTrials.gov.
What Is Bacteriostatic Water? A Lab-Reagent & Reconstitution Primer
What the 0.9% benzyl alcohol preservative does, how it differs from sterile water, and the general lab science of reconstitution, cited to the FDA label, USP, and peer-reviewed literature.
How to Read a Peptide COA (HPLC & Mass Spec), Step by Step
How HPLC reports purity, how mass spectrometry confirms identity, the difference between them, and how named labs like Janoshik and Colmaric publish verifiable batch reports.
BPC-157 vs TB-500: What the Recovery Research Shows
A research-use-only comparison of BPC-157 and TB-500 (thymosin beta-4) as research compounds: origin, mechanism, and published preclinical literature, cited to PubMed and Nature.
GHK-Cu: What the Copper-Peptide Research Shows
An overview of GHK-Cu, the copper tripeptide, covering what published studies report on collagen synthesis, fibroblast activity, and skin-remodeling research, cited to PubMed and PMC.
Retatrutide on Reddit: What the Research Community Is Discussing in 2026
The retatrutide questions the research community raises (COA/purity verification, storage stability, the published trials, and sourcing red flags), each answered in cited, past-tense research voice.
GLP-3R Explained: Retatrutide and the Glucagon Receptor
How published pharmacology describes GLP-3R (retatrutide) as a triple receptor agonist engaging the GLP-1, GIP, and glucagon receptors, cited to NEJM. Receptor pharmacology only.
GLOW Peptide Blend: Composition and What the Research Shows
What is in the GLOW blend (GHK-Cu, BPC-157, TB-500), what published research reports about each constituent separately, and why no published study has evaluated the combination itself.
KLOW Peptide Blend: Composition and What the Research Shows
What is in the KLOW blend (GHK-Cu, BPC-157, TB-500, KPV), how it differs from GLOW, and what the published literature reports about each constituent on its own.
KPV Peptide: What the Research Shows
A research-use-only overview of KPV, the C-terminal tripeptide of alpha-MSH: NF-kB signaling, PepT1 uptake, and colitis models, and why the evidence base is preclinical only.
Tesamorelin Peptide: Pharmacology and Regulatory Status
How published pharmacology and FDA records describe tesamorelin: a synthetic GHRH (1-44) analog acting at the GRF receptor, and its precise status as the active ingredient of a licensed biologic.
Is GHK-Cu FDA Approved? The Regulatory Status, Precisely
No. The precise, route-qualified regulatory record for GHK-Cu (prezatide copper): Drugs@FDA, the 503A bulks list, what happened with Category 2 in 2023, and why cosmetic use is not approval.